The path less costly.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 20944585.
- Also identified by DOI 10.1038/nbt1010-1018.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
When faced with a competitive threat, two companies took diametrically opposite approaches. Both were ultimately successful, but Genzyme's decision proved to be the cleaner and cheaper option.
Medical subject headings
- Drug Industry